Merz Therapeutics

Do you know the signs of a stroke? Let's make a commitment to improve our awareness and response to stroke symptoms. Recognizing the early signs can significantly improve the outcome and chances of recovery for those affected. The BE FAST stroke detection method is a critical tool for taking immediate action. Help us spread the word and make a difference!

We are excited to officially announce the launch of the "Access to Health" initiative at the World Stroke Congress! This collaboration with the World Stroke Organization is dedicated to reducing the burden of stroke in underserved communities across Sub-Saharan Africa, starting with Nigeria and Tanzania.    Stroke in sub-Saharan Africa is projected to increase dramatically, with an annual incidence rate of 316 cases per 100,000 people and a 3-year mortality rate of over 80%. These concerning statistics highlight the need for immediate action. Our commitment to health equity and improving stroke care access is stronger than ever.    Read the full press release: https://lnkd.in/eAgfJPjH #WSC24

Transforming patient care is about more than innovation; it's also about fostering collaborations that drive real, measurable progress. At Merz Therapeutics, we bring together expertise from around the world to address unmet medical needs and improve the quality of life for many. Learn more about how we're making a meaningful difference in the lives of patients around the world: https://lnkd.in/efZh7EJP

At Merz Therapeutics, we are passionate about making a profound impact on patients' lives. That's why we reinvest a significant portion of our revenues back into Research & Development. It enables us to address critical unmet medical needs and to further push the boundaries of science and innovation. Learn more about our R&D initiatives and how we're shaping the future of healthcare: https://lnkd.in/erXdfjsA

Ready, Steady... Grow! What an incredible three days we spent at the European Commercial Summit in Stockholm! Our teams from across Europe came together and explored strategies to accelerate growth and deliver greater value to people with neurological conditions. We're leaving this summit not only with new insights, but also with a shared vision and renewed excitement for the journey ahead. #BetterOutcomesForMorePatients #MerzTxEurope

Recently, we were thrilled to attend the International Congress on Parkinson's Disease and Movement Disorders. This important event brought together a global community of experts in the field of movement disorders and was filled with valuable discussions and groundbreaking research presentations. We would like to thank all the speakers, attendees and organizers who contributed to the success of the Congress! And a big thank you to our panel of medical experts at our lunch symposium for their valuable contributions: Pedro J Garcia Ruiz-Espiga, Alberto Espay, Stuart Isaacson, MD and Daniel Kremens.

At Merz Therapeutics, Global Medical Affairs is essential to aligning our scientific advancements with the real needs of people our therapies seek to support. Their role in gathering market insights and translating them into actionable strategies helps us drive innovation and improve patient outcomes. Learn more about our latest clinical breakthroughs: https://lnkd.in/erXdfjsA

Today is World Cerebral Palsy Day! Cerebral Palsy is a multifaceted neurological condition that affects millions of people worldwide. Cerebral palsy varies in severity and presents unique challenges that can affect an individual's ability to participate fully in daily life. Click through the images to find out more.

Understanding Parkinson's disease means recognizing the full range of its effects: OFF-episodes can be particularly complex and affect daily life for those affected in many ways. By increasing our awareness and sharing knowledge, we can drive more effective care and support. Let’s continue the conversation and collaborate for #BetterOutcomesForMorePatients.

We're excited to present our latest publication in collaboration with the Toxnet group, which focuses on the differences between adjunctive and multimodal therapies in spasticity management. This paper provides an evidence-based review of these therapeutic approaches and offers key clinical insights for selecting the appropriate therapies for patient care. This resource helps provide a more comprehensive training program and will complement the Toxnet curriculum and the GO-FAST app to better equip healthcare professionals with the knowledge they need. For a deeper understanding, explore the full paper here: https://lnkd.in/ezE-tm_F